Sirona Biochem (CVE:SBM) Reaches New 1-Year High at $0.31

Sirona Biochem Corp. (CVE:SBMGet Rating) hit a new 52-week high during mid-day trading on Thursday . The company traded as high as C$0.31 and last traded at C$0.29, with a volume of 677749 shares changing hands. The stock had previously closed at C$0.27.

The company has a debt-to-equity ratio of 2,620.27, a current ratio of 0.95 and a quick ratio of 0.93. The business’s fifty day moving average price is C$0.21 and its 200-day moving average price is C$0.20. The stock has a market capitalization of C$70.82 million and a price-to-earnings ratio of -18.75.

Sirona Biochem Company Profile (CVE:SBM)

Sirona Biochem Corp., a cosmetic ingredient and drug discovery company, develops and sells cosmetic and pharmaceutical active ingredients in Canada and France. Its programs include cosmetic skin lightener and diabetes drug; and other projects include the development of an anti-aging/cell protection library, novel anti-wrinkle compound, and anti-viral program.

See Also

Want More Great Investing Ideas?

Receive News & Ratings for Sirona Biochem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sirona Biochem and related companies with MarketBeat.com's FREE daily email newsletter.